‘Critical Step’ For Petros Toward ED Switch Proposal With OTC Label Comprehension Study

 
• By Malcolm Spicer
  
Petros Pharmaceuticals anticipates Drug Facts label technology it’s developing for potential switch of its Stendra ED drug also could be used for other OTC switch proposals. • Source: Petros Pharmaceuticals

More from Rx-to-OTC Switch

More from Health